May 2010 Volume 6, Issue 5
Volume 6, Issue 5 | May 2010
May 2010
In this Issue
Omics & Systems Biology
Common sense
GSK strikes $1.5 billion-plus deal to use Isis’ antisense platform for development of rare disease therapeuticsMaking siRNA research a SNALP
Tekmira to use stable nucleic acid-lipid particle technology to deliver Pfizer’s siRNA moleculesGene silencing takes steps forward
Dicerna Pharmaceuticals and Ipsen to collaborate on therapeutic agents in endocrinology and oncologyBuilding a better mousetrap
Affymetrix and Jackson Laboratory announce the official commercial launch of groundbreaking mouse diversity genotyping arrayGetting the bugs out of the flu
Emory University School of Medicine and Zirus team up to create new class of antiviral drugsGlobal News
An ironclad partnership
AMAG and Takeda announce strategic collaboration for iron deficiency anemia drug Ferahemesanofi-aventis inks diabetes test agreement with AgaMatrix
Companies to develop and market blood glucose marketing testsBanking on personalized medicine
Life Technologies and the Integrated Biobank of Luxembourg to sequence biospecimen samples for advancement of disease researchExpanding its footprint
AstraZeneca extends branded generics capability with Torrent agreementExpressing themselves
Eden Biodesign brings its cGMP manufacturing expertise together with Millipore’s UCOE express technologyGovernment Watch
Patent wars persist
Myriad poised to appeal court ruling invalidating patents on breast cancer genesWinners and losers in healthcare reform
New legislation has pros and cons for pharmaceutical industrySouthern comfort
Maine-based Jackson Laboratory may soon be in the position of opening a new facility in FloridaGenomics research takes hit in Minnesota
State-wide budget cuts mean less funding for Minnesota Partnership for Biotechnology and Medical GenomicsSpecial Reports
SPECIAL REPORT: Outsourcing under the microscope
As some companies tighten their belts, CROs across the globe are enjoying this growing business trendDiagnostics
Signed, sealed, delivered
PerkinElmer acquires diagnostic genetic testing firm Signature GenomicsPartnership is air for the lungs
Source BioScience inks deal with AstraZeneca to provide genetic testing service for lung cancerCompanies Seeq infectious disease answers
Novartis to market Smiths Detection’s Bio-Seeq instrument and technology for infectious disease diagnosticsBest served at room temperature: Just add water
GenVault provides GenTegra DNA to support cardio genetic testing at Berkeley HeartLabOptimizing breast cancer therapy strategies
Health Discovery and Smart Personalized Medicine to develop technology for lab tests aimed at personalized breast cancer therapyEditor's Focus
Autism story hits close to home for ddn reporter
The discoveries, technologies and advances involved in the deals our editors and reporters write about each month sometimes hit very close to home.Patent News
The Patent Reform Act of 2010: A substitute S. 515
Here comes the Patent Reform Act of 2010 in the form of an amendment to S. 515.Commentary
What drug discoverers should know about interferon and its future
A deeper understanding of interferons’ varied functions within the immune system may lead to discovery of more effective therapiesInstruments & Informatics
Deal is cut and dried
Luminex acquires automation firm BSD Robotics, expanding expertise in field of dry sample handlingTranscending clinical trial hurdles
Acquisition of TranSenda adds clinical trial management software to BioClinica’s portfolioQuality model + quality data = 250,000 molecules/hour
Symyx partners with Simulations Plus to improve predictive modeling of metabolites and metabolic pathwaysA good fit for sequencing
CLC bio partners with Ion Torrent to expand high-throughput sequencing supportResearch & Development
Resistance is futile
NeurOp and Bristol-Myers Squibb to develop NeurOp’s NMDAR antagonists in treatment-resistant depressionCancer research turns a corner
NCI taps Cornerstone Pharmaceuticals’ nanotechnology for evaluation of anti-cancer agentsAllies against autism
Rett Syndrome Research Trust, Melior Discovery to develop drug candidates for most disabling form of autismGiving a lymph to patients
Moffitt Cancer Center receives NCI grant to create bioengineered “designer” lymph nodes with Scripps FloridaNew Products
Plate-based, label-free biosensor
SRU Biosystems recently announced the extension of its product line of label-free instrumentation and biosensors with the introduction of its BIND Scanner, a plate-based, label-free instrument capable of monitoring cellular responses at an individual cell resolution.Feature
